These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 25275905)

  • 1. LOXL1-associated candidate epithelial pathomechanisms in exfoliation glaucoma.
    Laczko R; Szauter KM; Csiszar K
    J Glaucoma; 2014; 23(8 Suppl 1):S43-7. PubMed ID: 25275905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and regulation of LOXL1 and elastin-related genes in eyes with exfoliation syndrome.
    Zenkel M; Schlötzer-Schrehardt U
    J Glaucoma; 2014; 23(8 Suppl 1):S48-50. PubMed ID: 25275906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth Factors, Oxidative Damage, and Inflammation in Exfoliation Syndrome.
    Borrás T
    J Glaucoma; 2018 Jul; 27 Suppl 1(Suppl 1):S54-S60. PubMed ID: 29401156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extracellular Matrix Regulation and Dysregulation in Exfoliation Syndrome.
    Zenkel M
    J Glaucoma; 2018 Jul; 27 Suppl 1():S24-S28. PubMed ID: 29432335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular pathology of pseudoexfoliation syndrome/glaucoma--new insights from LOXL1 gene associations.
    Schlötzer-Schrehardt U
    Exp Eye Res; 2009 Apr; 88(4):776-85. PubMed ID: 18809397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of LOXL1 polymorphisms with pseudoexfoliation, glaucoma, intraocular pressure, and systemic diseases in a Greek population. The Thessaloniki eye study.
    Anastasopoulos E; Coleman AL; Wilson MR; Sinsheimer JS; Yu F; Katafigiotis S; Founti P; Salonikiou A; Pappas T; Koskosas A; Katopodi T; Lambropoulos A; Topouzis F
    Invest Ophthalmol Vis Sci; 2014 Jun; 55(7):4238-43. PubMed ID: 24917141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exfoliation syndrome: assembling the puzzle pieces.
    Pasquale LR; Borrás T; Fingert JH; Wiggs JL; Ritch R
    Acta Ophthalmol; 2016 Sep; 94(6):e505-12. PubMed ID: 26648185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ocular and systemic manifestations of exfoliation syndrome.
    Ritch R
    J Glaucoma; 2014; 23(8 Suppl 1):S1-8. PubMed ID: 25275896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LOXL1 deficiency in the lamina cribrosa as candidate susceptibility factor for a pseudoexfoliation-specific risk of glaucoma.
    Schlötzer-Schrehardt U; Hammer CM; Krysta AW; Hofmann-Rummelt C; Pasutto F; Sasaki T; Kruse FE; Zenkel M
    Ophthalmology; 2012 Sep; 119(9):1832-43. PubMed ID: 22633114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Composition of Exfoliation Material.
    Challa P; Johnson WM
    J Glaucoma; 2018 Jul; 27 Suppl 1():S29-S31. PubMed ID: 29965899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exfoliation syndrome and exfoliation glaucoma-associated LOXL1 variations are not involved in pigment dispersion syndrome and pigmentary glaucoma.
    Rao KN; Ritch R; Dorairaj SK; Kaur I; Liebmann JM; Thomas R; Chakrabarti S
    Mol Vis; 2008 Jul; 14():1254-62. PubMed ID: 18618003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of lysyl oxidase-like 1 (LOXL1) in exfoliation syndrome and glaucoma.
    Schlötzer-Schrehardt U; Zenkel M
    Exp Eye Res; 2019 Dec; 189():107818. PubMed ID: 31563608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lysyl oxidase-like 1-antisense 1 (LOXL1-AS1) lncRNA differentially regulates gene and protein expression, signaling and morphology of human ocular cells.
    Schmitt HM; Hake KM; Perkumas KM; Lê BM; Suarez MF; De Ieso ML; Rahman RS; Johnson WM; Gomez-Caraballo M; Ashley-Koch AE; Hauser MA; Stamer WD
    Hum Mol Genet; 2023 Oct; 32(21):3053-3062. PubMed ID: 37540217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Minimal phenotypes in transgenic mice with the human LOXL1/LOXL1-AS1 locus associated with exfoliation glaucoma.
    Meyer KJ; Mercer HE; Roos BR; Fingert JH; Anderson MG
    Vision Res; 2024 Oct; 223():108464. PubMed ID: 39151208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cellular and molecular biology of the iris, an overlooked tissue: the iris and pseudoexfoliation glaucoma.
    Borrás T
    J Glaucoma; 2014; 23(8 Suppl 1):S39-42. PubMed ID: 25275904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LOXL1 folding in exfoliation glaucoma.
    Bernstein AM; Ritch R; Wolosin JM
    Adv Protein Chem Struct Biol; 2019; 118():273-288. PubMed ID: 31928728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of LOXL1 gene polymorphisms in exfoliation syndrome and exfoliation glaucoma.
    Aragon-Martin JA; Ritch R; Liebmann J; O'Brien C; Blaaow K; Mercieca F; Spiteri A; Cobb CJ; Damji KF; Tarkkanen A; Rezaie T; Child AH; Sarfarazi M
    Mol Vis; 2008 Mar; 14():533-41. PubMed ID: 18385788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integral role for lysyl oxidase-like-1 in conventional outflow tissue function and behavior.
    Li G; Schmitt H; Johnson WM; Lee C; Navarro I; Cui J; Fleming T; Gomez-Caraballo M; Elliott MH; Sherwood JM; Hauser MA; Farsiu S; Ethier CR; Stamer WD
    FASEB J; 2020 Aug; 34(8):10762-10777. PubMed ID: 32623782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of novel LOXL1 genotyping method and evaluation of LOXL1, APOE and MTHFR polymorphisms in exfoliation syndrome/glaucoma in a Greek population.
    Chiras D; Tzika K; Kokotas H; Oliveira SC; Grigoriadou M; Kastania A; Dima K; Stefaniotou M; Aspiotis M; Petersen MB; Kroupis C; Kitsos G
    Mol Vis; 2013; 19():1006-16. PubMed ID: 23687437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lysyl oxidase-like 1 gene polymorphisms in German patients with normal tension glaucoma, pigmentary glaucoma and exfoliation glaucoma.
    Wolf C; Gramer E; Müller-Myhsok B; Pasutto F; Gramer G; Wissinger B; Weisschuh N
    J Glaucoma; 2010 Feb; 19(2):136-41. PubMed ID: 19373106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.